243 related articles for article (PubMed ID: 22630082)
1. TGF-beta: a master switch in tumor immunity.
Gigante M; Gesualdo L; Ranieri E
Curr Pharm Des; 2012; 18(27):4126-34. PubMed ID: 22630082
[TBL] [Abstract][Full Text] [Related]
2. Transforming Growth Factor-β Signaling in Immunity and Cancer.
Batlle E; Massagué J
Immunity; 2019 Apr; 50(4):924-940. PubMed ID: 30995507
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived transforming growth factor-β is critical for tumor progression and evasion from immune surveillance.
Li Z; Zhang LJ; Zhang HR; Tian GF; Tian J; Mao XL; Jia ZH; Meng ZY; Zhao LQ; Yin ZN; Wu ZZ
Asian Pac J Cancer Prev; 2014; 15(13):5181-6. PubMed ID: 25040972
[TBL] [Abstract][Full Text] [Related]
4. Natural innate and adaptive immunity to cancer.
Vesely MD; Kershaw MH; Schreiber RD; Smyth MJ
Annu Rev Immunol; 2011; 29():235-71. PubMed ID: 21219185
[TBL] [Abstract][Full Text] [Related]
5. Impairment of NKG2D-Mediated Tumor Immunity by TGF-β.
Lazarova M; Steinle A
Front Immunol; 2019; 10():2689. PubMed ID: 31803194
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression.
van den Bulk J; de Miranda NFCC; Ten Dijke P
Clin Sci (Lond); 2021 Jan; 135(1):35-52. PubMed ID: 33399850
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.
Yang L; Pang Y; Moses HL
Trends Immunol; 2010 Jun; 31(6):220-7. PubMed ID: 20538542
[TBL] [Abstract][Full Text] [Related]
8. Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy.
Zhao H; Wei J; Sun J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107101. PubMed ID: 33099067
[TBL] [Abstract][Full Text] [Related]
9. Tumor immune escape mechanisms that operate during metastasis.
Croci DO; Salatino M
Curr Pharm Biotechnol; 2011 Nov; 12(11):1923-36. PubMed ID: 21470132
[TBL] [Abstract][Full Text] [Related]
10. The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance.
Chang RB; Beatty GL
J Leukoc Biol; 2020 Jul; 108(1):363-376. PubMed ID: 32272502
[TBL] [Abstract][Full Text] [Related]
11. Tumor immunoediting and immunosculpting pathways to cancer progression.
Reiman JM; Kmieciak M; Manjili MH; Knutson KL
Semin Cancer Biol; 2007 Aug; 17(4):275-87. PubMed ID: 17662614
[TBL] [Abstract][Full Text] [Related]
12. Effects of TGF-beta on the immune system: implications for cancer immunotherapy.
de Visser KE; Kast WM
Leukemia; 1999 Aug; 13(8):1188-99. PubMed ID: 10450746
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta: a master immune regulator.
Larson C; Oronsky B; Carter CA; Oronsky A; Knox SJ; Sher D; Reid TR
Expert Opin Ther Targets; 2020 May; 24(5):427-438. PubMed ID: 32228232
[No Abstract] [Full Text] [Related]
14. Tuning cancer fate: the unremitting role of host immunity.
Calì B; Molon B; Viola A
Open Biol; 2017 Apr; 7(4):. PubMed ID: 28404796
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages: a short compendium.
Prenen H; Mazzone M
Cell Mol Life Sci; 2019 Apr; 76(8):1447-1458. PubMed ID: 30747250
[TBL] [Abstract][Full Text] [Related]
16. Major fundamental factors hindering immune system in defense against tumor cells: The link between insufficiency of innate immune responses, metabolism, and neurotransmitters with effector immune cells disability.
Bahrambeigi S; Sanajou D; Shafiei-Irannejad V
Immunol Lett; 2019 Aug; 212():81-87. PubMed ID: 31260743
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
18. Blockade of TGF-β signaling: a potential target for cancer immunotherapy?
Ungefroren H
Expert Opin Ther Targets; 2019 Aug; 23(8):679-693. PubMed ID: 31232607
[No Abstract] [Full Text] [Related]
19. The immunobiology of cancer immunosurveillance and immunoediting.
Dunn GP; Old LJ; Schreiber RD
Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta-based immunotherapy for cancer: breaching the tumor firewall.
Shah AH; Lee C
Prostate; 2000 Oct; 45(2):167-72. PubMed ID: 11027416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
